ABOS insider buying & filings

ABOSAcumen Pharmaceuticals, Inc.

NasdaqGS · Healthcare · $189.96M

$2.20

+3.58% · Sep 15

66 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Jun 17 · scanned 41m ago

Price · 1Y · daily● 46 sells

▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$189.96M

Float

37.0M

51% public

Short % float

Pro

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Jun 17SELLPorter DerrellDirectordirect13,040 @ $2.33$30.3K

Jun 17EXERCISEPorter DerrellDirectordirect13,040 @ $1.07$14.0K

Jun 17SELLPorter DerrellDirectordirect12,800 @ $2.33$29.8K

Jun 17SELLPorter DerrellDirectordirect6,460 @ $2.35$15.1K

Jun 17EXERCISEPorter DerrellDirectordirect6,460 @ $1.07$6.9K

Context

Wall St

$7.40 avg target

+236.4% vs today · 5 analysts

▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice

Earnings · EPS vs forecast

3 of 4 quarters beat

Q1 '26−$0.33 act+$0.13

Q4 '25−$0.41 act+$0.15

Q3 '25−$0.44 act+$0.24

Q2 '25−$0.68 act−$0.16

Coverage

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice